Significance of MRI in diagnosis and differential diagnosis of Parkinson's disease

Neurodegenerative Diseases

Volumn 7, Issue 5, 2010, Pages 300-318

  Mahlknecht, Philipp ^a   Hotter, Anna ^a   Hussl, Anna ^a   Esterhammer, Regina ^a   Schocke, Michael ^a   Seppi, Klaus ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Atypical parkinsonian disorders; Corticobasal degeneration; Diffusion; Magnetic resonance imaging; Multiple system atrophy; Parkinson's disease; Progressive supranuclear palsy

Indexed keywords

BASAL GANGLION; BRAIN ISCHEMIA; BRAIN TUMOR; CORTICOBASAL DEGENERATION; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE SUPRANUCLEAR PALSY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SHY DRAGER SYNDROME; ANIMAL; ATROPHY; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; IMAGE PROCESSING; PATHOLOGY;

ANIMALS; ATROPHY; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; EARLY DIAGNOSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE;

EID: 77954250857     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000314495     Document Type: Review

References (160)

1. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
2. Tolosa E, Wenning G, Poewe W: The diagnosis of Parkinson's disease. Lancet Neurol 2006; 5: 75-86.
3. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al: Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676.
4. Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al: Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDSSPSP International Workshop. Neurology 1996; 47: 1-9.
5. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, et al: Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003; 18: 467-486.
6. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ: What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992; 42: 1142-1146.
7. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ: The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002; 125: 861-870.
8. Rajput AH, Rozdilsky B, Rajput A: Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991; 18: 275-278.
9. Jankovic J, Rajput AH, McDermott MP, Perl DP: The evolution of diagnosis in early Parkinson disease. Parkinson Study Group. Arch Neurol 2000; 57: 369-372.
10. Litvan I, Mangone CA, McKee A, Verny M, Parsa A, Jellinger K, et al: Natural history of progressive supranuclear palsy (Steele-Richardson- Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996; 60: 615-620.
11. Rinne JO, Lee MS, Thompson PD, Marsden CD: Corticobasal degeneration. A clinical study of 36 cases. Brain 1994; 117: 1183-1196.
12. Wenning GK, Ben SY, Magalhaes M, Daniel SE, Quinn NP: Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. Brain 1994; 117: 835-845.
13. Wenning GK, Litvan I, Jankovic J, Granata R, Mangone CA, McKee A, et al: Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998; 64: 184-189.
14. Dickson DW, Rademakers R, Hutton ML: Progressive supranuclear palsy: pathology and genetics. Brain Pathol 2007; 17: 74-82.
15. Marras C, Lang A: Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain. Neurology 2008; 70: 1996-2003.
16. Muller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I: Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 2000; 55: 888-891.
17. Seppi K, Yekhlef F, Diem A, Luginger WE, Mueller J, Tison F, et al: Progression of parkinsonism in multiple system atrophy. J Neurol 2005; 252: 91-96. (Pubitemid 40179024)
18. Lang AE, Lozano AM: Parkinson's disease. Second of two parts. N Engl J Med 1998; 339: 1130-1143.
19. Lang AE, Lozano AM: Parkinson's disease. First of two parts. N Engl J Med 1998; 339: 1044-1053.
20. Drayer BP, Olanow W, Burger P, Johnson GA, Herfkens R, Riederer S: Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986; 159: 493-498.
21. Pastakia B, Polinsky R, Di CG, Simmons JT, Brown R, Wener L: Multiple system atrophy (Shy-Drager syndrome): MR imaging. Radiology 1986; 159: 499-502.
22. Farrall A: Magnetic resonance imaging: how to understand it. Pract Neurol 2006; 6: 318-325.
23. McGowan JC: Basic principles of magnetic resonance imaging. Neuroimaging Clin N Am 2008; 18: 623-636.
24. Duguid JR, De La PR, DeGroot J: Magnetic resonance imaging of the midbrain in Parkinson's disease. Ann Neurol 1986; 20: 744-747.
25. Gupta A, Dawson VL, Dawson TM: What causes cell death in Parkinson's disease? Ann Neurol 2008; 64(suppl 2):S3-S15.
26. Hirsch EC, Hunot S: Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 2009; 8: 382-397.
27. Brass SD, Chen NK, Mulkern RV, Bakshi R: Magnetic resonance imaging of iron deposition in neurological disorders. Top Magn Reson Imaging 2006; 17: 31-40.
28. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, et al: Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005; 23: 1-25.
29. Righini A, Antonini A, Ferrarini M, De NR, Canesi M, Triulzi F, et al: Thin section MR study of the basal ganglia in the differential diagnosis between striatonigral degeneration and Parkinson disease. J Comput Assist Tomogr 2002; 26: 266-271.
30. Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM: Principles, techniques, and applications of T2 * -based MR imaging and its special applications. Radiographics 2009; 29: 1433-1449.
31. Schwarz J, Weis S, Kraft E, Tatsch K, Bandmann O, Mehraein P, et al: Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy. J Neurol Neurosurg Psychiatry 1996; 60: 98-101.
32. Lee WH, Lee CC, Shyu WC, Chong PN, Lin SZ: Hyperintense putaminal rim sign is not a hallmark of multiple system atrophy at 3T. AJNR Am J Neuroradiol 2005; 26: 2238-2242.
33. Brant-Zawadzki M, Gillan GD, Nitz WR: MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence - initial experience in the brain. Radiology 1992; 182: 769-775.
34. Hutchinson M, Raff U: Parkinson's disease: a novel MRI method for determining structural changes in the substantia nigra. J Neurol Neurosurg Psychiatry 1999; 67: 815-818.
35. Hutchinson M, Raff U, Lebedev S: MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM). Neuroimage 2003; 20: 1899-1902.
36. Hutchinson M, Raff U: Detection of Parkinson's disease by MRI: spin-lattice distribution imaging. Mov Disord 2008; 23: 1991-1997.
37. Brooks DJ: Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. J Neurol 2000; 247(suppl 2):II11-II18.
38. Seppi K, Schocke MF: An update on conventional and advanced magnetic resonance imaging techniques in the differential diagnosis of neurodegenerative parkinsonism. Curr Opin Neurol 2005; 18: 370-375.
39. Jokinen P, Bruck A, Aalto S, Forsback S, Parkkola R, Rinne JO: Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkinsonism Relat Disord 2009; 15: 88-93.
40. Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S: Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 1987; 149: 365-379.
41. Savoiardo M: Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging. Neurol Sci 2003; 24(suppl 1):S35-S37.
42. Hu MT, White SJ, Herlihy AH, Chaudhuri KR, Hajnal JV, Brooks DJ: A comparison of (18)F-dopa PET and inversion recovery MRI in the diagnosis of Parkinson's disease. Neurology 2001; 56: 1195-1200.
43. Minati L, Grisoli M, Carella F, De ST, Bruzzone MG, Savoiardo M: Imaging degeneration of the substantia nigra in Parkinson disease with inversion-recovery MR imaging. AJNR Am J Neuroradiol 2007; 28: 309-313.
44. Heiss WD, Hilker R: The sensitivity of 18-fluorodopa positron emission tomography and magnetic resonance imaging in Parkinson's disease. Eur J Neurol 2004; 11: 5-12.
45. Krauss JK, Paduch T, Mundinger F, Seeger W: Parkinsonism and rest tremor secondary to supratentorial tumours sparing the basal ganglia. Acta Neurochir (Wien) 1995; 133: 22-29.
46. Manyam BV, Bhatt MH, Moore WD, Devleschoward AB, Anderson DR, Calne DB: Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol 1992; 31: 379-384.
47. Saatci I, Topcu M, Baltaoglu FF, Kose G, Yalaz K, Renda Y, et al: Cranial MR findings in Wilson's disease. Acta Radiol 1997; 38: 250-258.
48. Sibon I, Fenelon G, Quinn NP, Tison F: Vascular parkinsonism. J Neurol 2004; 251: 513-524. (Pubitemid 38680292)
49. Tranchant C, Bhatia KP, Marsden CD: Movement disorders in multiple sclerosis. Mov Disord 1995; 10: 418-423.
50. McNeill A, Birchall D, Hayflick SJ, Gregory A, Schenk JF, Zimmerman EA, et al: T2 * and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008; 70: 1614-1649.
51. Schrag A, Kingsley D, Phatouros C, Mathias CJ, Lees AJ, Daniel SE, et al: Clinical usefulness of magnetic resonance imaging in multiple system atrophy. J Neurol Neurosurg Psychiatry 1998; 65: 65-71.
52. Abe K, Hikita T, Yokoe M, Mihara M, Sakoda S: The 'cross' signs in patients with multiple system atrophy: a quantitative study. J Neuroimaging 2006; 16: 73-77.
53. Kraft E, Schwarz J, Trenkwalder C, Vogl T, Pfluger T, Oertel WH: The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol 1999; 56: 225-228.
54. Lee EA, Cho HI, Kim SS, Lee WY: Comparison of magnetic resonance imaging in subtypes of multiple system atrophy. Parkinsonism Relat Disord 2004; 10: 363-368.
55. Bhattacharya K, Saadia D, Eisenkraft B, Yahr M, Olanow W, Drayer B, et al: Brain magnetic resonance imaging in multiple-system atrophy and Parkinson disease: a diagnostic algorithm. Arch Neurol 2002; 59: 835-842.
56. Horimoto Y, Aiba I, Yasuda T, Ohkawa Y, Katayama T, Yokokawa Y, et al: Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course? J Neurol 2002; 249: 847-854.
57. Watanabe H, Saito Y, Terao S, Ando T, Kachi T, Mukai E, et al: Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. Brain 2002; 125: 1070-1083.
58. Schocke MF, Seppi K, Esterhammer R, Kremser C, Jaschke W, Poewe W, et al: Diffusion- weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD. Neurology 2002; 58: 575-580.
59. Ito S, Shirai W, Hattori T: Evaluating posterolateral linearization of the putaminal margin with magnetic resonance imaging to diagnose the Parkinson variant of multiple system atrophy. Mov Disord 2007; 22: 578-581.
60. Yekhlef F, Ballan G, Macia F, Delmer O, Sourgen C, Tison F: Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD. J Neural Transm 2003; 110: 151-169.
61. Kraft E, Trenkwalder C, Auer DP: T2 * - weighted MRI differentiates multiple system atrophy from Parkinson's disease. Neurology 2002; 59: 1265-1267.
62. von Lewinski F, Werner C, Jorn T, Mohr A, Sixel-Doring F, Trenkwalder C: T2 * -weighted MRI in diagnosis of multiple system atrophy. A practical approach for clinicians. J Neurol 2007; 254: 1184-1188.
63. Schrag A, Good CD, Miszkiel K, Morris HR, Mathias CJ, Lees AJ, et al: Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000; 54: 697-702.
64. Barsottini OG, Ferraz HB, Maia AC Jr, Silva CJ, Rocha AJ: Differentiation of Parkinson's disease and progressive supranuclear palsy with magnetic resonance imaging: the first Brazilian experience. Parkinsonism Relat Disord 2007; 13: 389-393.
65. Oba H, Yagishita A, Terada H, Barkovich AJ, Kutomi K, Yamauchi T, et al: New and reliable MRI diagnosis for progressive supranuclear palsy. Neurology 2005; 64: 2050-2055.
66. Sitburana O, Ondo WG: Brain magnetic resonance imaging (MRI) in parkinsonian disorders. Parkinsonism Relat Disord 2009; 15: 165-174.
67. Slowinski J, Imamura A, Uitti RJ, Pooley RA, Strongosky AJ, Dickson DW, et al: MR imaging of brainstem atrophy in progressive supranuclear palsy. J Neurol 2008; 255: 37-44.
68. Soliveri P, Monza D, Paridi D, Radice D, Grisoli M, Testa D, et al: Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999; 53: 502-507.
69. Righini A, Antonini A, De Notaris R, Bianchini E, Meucci N, Sacilotto G, et al: MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. AJNR Am J Neuroradiol 2004; 25: 927-932.
70. Warmuth-Metz M, Naumann M, Csoti I, Solymosi L: Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. Arch Neurol 2001; 58: 1076-1079.
71. Graber JJ, Staudinger R: Teaching NeuroImages: 'Penguin' or 'hummingbird' sign and midbrain atrophy in progressive supranuclear palsy. Neurology 2009; 72:e81.
72. Kato N, Arai K, Hattori T: Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 2003; 210: 57-60.
73. Paviour DC, Price SL, Stevens JM, Lees AJ, Fox NC: Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy. Neurology 2005; 64: 675-679.
74. Kataoka H, Tonomura Y, Taoka T, Ueno S: Signal changes of superior cerebellar peduncle on fluid-attenuated inversion recovery in progressive supranuclear palsy. Parkinsonism Relat Disord 2008; 14: 63-65.
75. Hauser RA, Murtaugh FR, Akhter K, Gold M, Olanow CW: Magnetic resonance imaging of corticobasal degeneration. J Neuroimaging 1996; 6: 222-226.
76. Josephs KA, Tang-Wai DF, Edland SD, Knopman DS, Dickson DW, Parisi JE, et al: Correlation between antemortem magnetic resonance imaging findings and pathologically confirmed corticobasal degeneration. Arch Neurol 2004; 61: 1881-1884.
77. Hassan A, Whitwell JL, Boeve BF, Jack CR Jr, Parisi JE, Dickson DW, et al: Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord 2010; 16: 208-214.
78. Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.
79. Minnerop M, Specht K, Ruhlmann J, Schimke N, Abele M, Weyer A, et al: Voxelbased morphometry and voxel-based relaxometry in multiple system atrophy - a comparison between clinical subtypes and correlations with clinical parameters. Neuroimage 2007; 36: 1086-1095.
80. Specht K, Minnerop M, Muller-Hubenthal J, Klockgether T: Voxel-based analysis of multiple-system atrophy of cerebellar type: complementary results by combining voxelbased morphometry and voxel-based relaxometry. Neuroimage 2005; 25: 287-293.
81. Nicoletti G, Fera F, Condino F, Auteri W, Gallo O, Pugliese P, et al: MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease. Radiology 2006; 239: 825-830.
82. Quattrone A, Nicoletti G, Messina D, Fera F, Condino F, Pugliese P, et al: MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008; 246: 214-221.
83. Cosottini M, Ceravolo R, Faggioni L, Lazzarotti G, Michelassi MC, Bonuccelli U, et al: Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging. Acta Neurol Scand 2007; 116: 37-42.
84. Cordato NJ, Pantelis C, Halliday GM, Velakoulis D, Wood SJ, Stuart GW, et al: Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. Brain 2002; 125: 789-800.
85. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD: Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J Neurol Neurosurg Psychiatry 2002; 73: 517-523.
86. Groschel K, Hauser TK, Luft A, Patronas N, Dichgans J, Litvan I, et al: Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration. Neuroimage 2004; 21: 714-724.
87. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC: Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico- radiological correlations. Mov Disord 2006; 21: 989-996.
88. Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, Voigt K, et al: Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol 1999; 45: 65-74.
89. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, et al: Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: an MRI study. Neurology 1996; 46: 678-681.
90. Menke RA, Scholz J, Miller KL, Deoni S, Jbabdi S, Matthews PM, et al: MRI characteristics of the substantia nigra in Parkinson's disease: a combined quantitative T1 and DTI study. Neuroimage 2009; 47: 435-441.
91. Ibarretxe-Bilbao N, Junque C, Tolosa E, Marti MJ, Valldeoriola F, Bargallo N, et al: Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci 2009; 30: 1162-1171.
92. Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT: Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004; 127: 791-800.
93. Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, et al: Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 2005; 64: 224-229.
94. Sanchez-Castaneda C, Rene R, Ramirez- Ruiz B, Campdelacreu J, Gascon J, Falcon C, et al: Correlations between gray matter reductions and cognitive deficits in dementia with Lewy Bodies and Parkinson's disease with dementia. Mov Disord 2009; 24: 1740-1746.
95. Summerfield C, Junque C, Tolosa E, Salgado- Pineda P, Gomez-Anson B, Marti MJ, et al: Structural brain changes in Parkinson disease with dementia: a voxel-based morphometry study. Arch Neurol 2005; 62: 281-285.
96. Brenneis C, Seppi K, Schocke MF, Muller J, Luginger E, Bosch S, et al: Voxel-based morphometry detects cortical atrophy in the Parkinson variant of multiple system atrophy. Mov Disord 2003; 18: 1132-1138.
97. Brenneis C, Boesch SM, Egger KE, Seppi K, Scherfler C, Schocke M, et al: Cortical atrophy in the cerebellar variant of multiple system atrophy: a voxel-based morphometry study. Mov Disord 2006; 21: 159-165.
98. Specht K, Minnerop M, Abele M, Reul J, Wullner U, Klockgether T: In vivo voxelbased morphometry in multiple system atrophy of the cerebellar type. Arch Neurol 2003; 60: 1431-1435. (Pubitemid 37248805)
99. Brenneis C, Egger K, Scherfler C, Seppi K, Schocke M, Poewe W, et al: Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study. J Neurol 2007; 254: 191-196.
100. Tzarouchi LC, Astrakas LG, Kontsiotis S, Tsouli S, Margariti P, Zikou A, et al: Voxelbased morphometry and voxel-based relaxometry in parkinsonian variant of multiple system atrophy. J Neuroimaging 2009, Epub ahead of print.
101. Brenneis C, Seppi K, Schocke M, Benke T, Wenning GK, Poewe W: Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2004; 75: 246-249.
102. Padovani A, Borroni B, Brambati SM, Agosti C, Broli M, Alonso R, et al: Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2006; 77: 457-463.
103. Price S, Paviour D, Scahill R, Stevens J, Rossor M, Lees A, et al: Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease. Neuroimage 2004; 23: 663-669.
104. Boxer AL, Geschwind MD, Belfor N, Gorno- Tempini ML, Schauer GF, Miller BL, et al: Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol 2006; 63: 81-86.
105. Ridgway GR, Henley SM, Rohrer JD, Scahill RI, Warren JD, Fox NC: Ten simple rules for reporting voxel-based morphometry studies. Neuroimage 2008; 40: 1429-1435.
106. Le BD: Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4: 469-480.
107. Hagmann P, Jonasson L, Maeder P, Thiran JP, Wedeen VJ, Meuli R: Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 2006; 26(suppl 1):S205-S223.
108. Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair KJ, Czermak BV, et al: Trace of diffusion tensor differentiates the Parkinson variant of multiple system atrophy and Parkinson's disease. Neuroimage 2004; 21: 1443-1451.
109. Wolff SD, Balaban RS: Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn Reson Med 1989; 10: 135-144.
110. van Buchem MA, McGowan JC, Grossman RI: Magnetization transfer histogram methodology: its clinical and neuropsychological correlates. Neurology 1999; 53(suppl 3):S23-S28.
111. Fazekas F, Ropele S, Enzinger C, Gorani F, Seewann A, Petrovic K, et al: MTI of white matter hyperintensities. Brain 2005; 128: 2926-2932.
112. Blain CR, Barker GJ, Jarosz JM, Coyle NA, Landau S, Brown RG, et al: Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI. Neurology 2006; 67: 2199-2205.
113. Paviour DC, Thornton JS, Lees AJ, Jager HR: Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy. Mov Disord 2007; 22: 68-74.
114. Seppi K, Schocke MF, Esterhammer R, Kremser C, Brenneis C, Mueller J, et al: Diffusion- weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy. Neurology 2003; 60: 922-927.
115. Seppi K, Schocke MF, Donnemiller E, Esterhammer R, Kremser C, Scherfler C, et al: Comparison of diffusion-weighted imaging and [123I]IBZM-SPECT for the differentiation of patients with the Parkinson variant of multiple system atrophy from those with Parkinson's disease. Mov Disord 2004; 19: 1438-1445.
116. Chan LL, Rumpel H, Yap K, Lee E, Loo HV, Ho GL, et al: Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry 2007; 78: 1383-1386.
117. Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, et al: High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease. Neurology 2009; 72: 1378-1384.
118. Yoshikawa K, Nakata Y, Yamada K, Nakagawa M: Early pathological changes in the parkinsonian brain demonstrated by diffusion tensor MRI. J Neurol Neurosurg Psychiatry 2004; 75: 481-484.
119. Gattellaro G, Minati L, Grisoli M, Mariani C, Carella F, Osio M, et al: White matter involvement in idiopathic Parkinson disease: a diffusion tensor imaging study. AJNR Am J Neuroradiol 2009; 30: 1222-1226.
120. Fearnley JM, Lees AJ: Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991; 114: 2283-2301.
121. Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P: Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 2008; 29: 501-505.
122. Tessa C, Giannelli M, Della NR, Lucetti C, Berti C, Ginestroni A, et al: A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol 2008; 29: 674-680.
123. Scherfler C, Schocke MF, Seppi K, Esterhammer R, Brenneis C, Jaschke W, et al: Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease. Brain 2006; 129: 538-542.
124. Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al: Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008; 63: 167-173.
125. Seppi K, Schocke MF, Prennschuetz- Schuetzenau K, Mair KJ, Esterhammer R, Kremser C, et al: Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study. Mov Disord 2006; 21: 847-852.
126. Nicoletti G, Lodi R, Condino F, Tonon C, Fera F, Malucelli E, et al: Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain 2006; 129: 2679-2687.
127. Ito M, Watanabe H, Kawai Y, Atsuta N, Tanaka F, Naganawa S, et al: Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy. J Neurol Neurosurg Psychiatry 2007; 78: 722-728.
128. Kollensperger M, Seppi K, Liener C, Boesch S, Heute D, Mair KJ, et al: Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy. Mov Disord 2007; 22: 1771-1776.
129. Pellecchia MT, Barone P, Mollica C, Salvatore E, Ianniciello M, Longo K, et al: Diffusion- weighted imaging in multiple system atrophy: a comparison between clinical subtypes. Mov Disord 2009; 24: 689-696.
130. Seppi K, Schocke MF, Mair KJ, Esterhammer R, Scherfler C, Geser F, et al: Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 2006; 31: 240-245. (Pubitemid 43728996)
131. Kanazawa M, Shimohata T, Terajima K, Onodera O, Tanaka K, Tsuji S, et al: Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion- weighted MR imaging. J Neurol 2004; 251: 1121-1124.
132. Rizzo G, Martinelli P, Manners D, Scaglione C, Tonon C, Cortelli P, et al: Diffusionweighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 2008; 131: 2690-2700.
133. Nicoletti G, Tonon C, Lodi R, Condino F, Manners D, Malucelli E, et al: Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease. Mov Disord 2008; 23: 2370-2376.
134. Erbetta A, Mandelli ML, Savoiardo M, Grisoli M, Bizzi A, Soliveri P, et al: Diffusion tensor imaging shows different topographic involvement of the thalamus in progressive supranuclear palsy and corticobasal degeneration. AJNR Am J Neuroradiol 2009; 30: 1482-1487.
135. Boelmans K, Kaufmann J, Bodammer N, Ebersbach G, Behlau G, Heinze HJ, et al: Involvement of motor pathways in corticobasal syndrome detected by diffusion tensor tractography. Mov Disord 2009; 24: 168-175.
136. Anik Y, Iseri P, Demirci A, Komsuoglu S, Inan N: Magnetization transfer ratio in early period of Parkinson disease. Acad Radiol 2007; 14: 189-192.
137. da Rocha AJ, Maia AC Jr, da Silva CJ, Braga FT, Ferreira NP, Barsottini OG, et al: Pyramidal tract degeneration in multiple system atrophy: the relevance of magnetization transfer imaging. Mov Disord 2007; 22: 238-244.
138. Eckert T, Sailer M, Kaufmann J, Schrader C, Peschel T, Bodammer N, et al: Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging. Neuroimage 2004; 21: 229-235.
139. Tambasco N, Pelliccioli GP, Chiarini P, Montanari GE, Leone F, Mancini ML, et al: Magnetization transfer changes of grey and white matter in Parkinson's disease. Neuroradiology 2003; 45: 224-230.
140. Trabesinger AH, Meier D, Boesiger P: In vivo 1H NMR spectroscopy of individual human brain metabolites at moderate field strengths. Magn Reson Imaging 2003; 21: 1295-1302.
141. Firbank MJ, Harrison RM, O'Brien JT: A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dement Geriatr Cogn Disord 2002; 14: 64-76.
142. Schocke MF, Berger T, Felber SR, Wolf C, Deisenhammer F, Kremser C, et al: Serial contrast-enhanced magnetic resonance imaging and spectroscopic imaging of acute multiple sclerosis lesions under highdose methylprednisolone therapy. Neuroimage 2003; 20: 1253-1263.
143. Federico F, Simone IL, Lucivero V, Iliceto G, de MM, Giannini P, et al: Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders. Mov Disord 1997; 12: 903-909. (Pubitemid 27496766)
144. Federico F, Simone IL, Lucivero V, Mezzapesa DM, de Mari M, Lamberti P, et al: Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes. Ital J Neurol Sci 1999; 20: 223-229.
145. Federico F, Simone IL, Lucivero V, de Mari M, Giannini P, Iliceto G, et al: Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 1997; 62: 239-242. (Pubitemid 27117251)
146. Davie CA, Wenning GK, Barker GJ, Tofts PS, Kendall BE, Quinn N, et al: Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995; 37: 204-210.
147. Chaudhuri KR, Lemmens GM, Williams SC, Ellis C, Lloyd CM, Dawson J, et al: Proton magnetic resonance spectroscopy of the striatum in Parkinson's disease patients with motor response fluctuations. Parkinsonism Relat Disord 1996; 2: 63-67.
148. Clarke CE, Lowry M: Systematic review of proton magnetic resonance spectroscopy of the striatum in parkinsonian syndromes. Eur J Neurol 2001; 8: 573-577.
149. Watanabe H, Fukatsu H, Katsuno M, Sugiura M, Hamada K, Okada Y, et al: Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. J Neurol Neurosurg Psychiatry 2004; 75: 103-109.
150. Schrag A, Ben-Shlomo Y, Quinn N: How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry 2002; 73: 529-534.
151. Williams DR, Lees AJ: How do patients with parkinsonism present? A clinicopathological study. Intern Med J 2009; 39: 7-12.
152. Osaki Y, Ben-Shlomo Y, Lees AJ, Daniel SE, Colosimo C, Wenning G, et al: Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004; 19: 181-189.
153. Osaki Y, Wenning GK, Daniel SE, Hughes A, Lees AJ, Mathias CJ, et al: Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002; 59: 1486-1491.
154. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, et al: Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005; 128(Pt 6): 1247-1258.
155. Wadia PM, Lang AE: The many faces of corticobasal degeneration. Parkinsonism Relat Disord 2007; 13(suppl 3):S336-S340.
156. Shiga K, Yamada K, Yoshikawa K, Mizuno T, Nishimura T, Nakagawa M: Local tissue anisotropy decreases in cerebellopetal fibers and pyramidal tract in multiple system atrophy. J Neurol 2005; 252: 589-596.
157. Schuff N: Potential role of high-field MRI for studies in Parkinson's disease. Mov Disord 2009; 24(suppl 2):S684-S690.
158. van Nuenen BF, van Eimeren T, van der Vegt JP, Buhmann C, Klein C, Bloem BR, et al: Mapping preclinical compensation in Parkinson's disease: an imaging genomics approach. Mov Disord 2009; 24(suppl 2): S703-S710.
159. Nilsson C, Markenroth BK, Brockstedt S, Latt J, Widner H, Larsson EM: Tracking the neurodegeneration of parkinsonian disorders - a pilot study. Neuroradiology 2007; 49: 111-119.
160. Tir M, Delmaire C, le Thuc V, Duhamel A, Destee A, Pruvo JP, Defebvre L: Motor-related circuit dysfunction in MSA-P: usefulness of combined whole-brain imaging analysis. Mov Disord 2009; 24: 863-870.